RG
Raffaella Greco
Research areas: Medicine · Hematology · Hematopoietic Stem Cell Transplantation · Transplantation: Methods and Outcomes · Renal Transplantation Outcomes and Treatments
0000-0002-6117-5328
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (137)
- The role of palliative and supportive care in haematopoietic cell transplantation and cellular therapy. Recommendations from the EBMT practice harmonisation and guidelines committee Save
- Empirical Therapy in High-Risk Hematological Patients with Carbapenem-Resistant Enterobacterales Colonization: Real-World Treatment Decisions and Antimicrobial Stewardship Implications Save
- Baseline liver stiffness predicts SOS/VOD after allogeneic hematopoietic stem cell transplantation Save
- Late complications after autologous HSCT for autoimmune diseases: a retrospective survey from the autoimmune diseases working party (ADWP), transplant complications working party (TCWP) and paediatric diseases working party (PDWP) of the european society… Save
- Predicting Relapse After Autologous Hematopoietic Cell Transplantation in Systemic Sclerosis: What Autoantibodies Can and Cannot Tell Us Save
- The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy Save
- An extraction pipeline for analysis of hematopoietic stem cell transplantation data Save
- Antibacterial prophylaxis and antimicrobial stewardship in the era of innovative therapies for haematological malignancies: transplantation, cellular therapies and new drugs Save
- Impact of busulfan- versus treosulfan-based conditioning on the incidence of sinusoidal obstruction syndrome/veno-occlusive disease after allogeneic hematopoietic cell transplantation: a dual-center real-world study Save
- BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party Save
- Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations Save
- Allogeneic CAR-T cells in lupus: Bridging the gap for a new therapeutic era? Save
- Anti-B-cell CAR-T therapy in multiple sclerosis is simply a more profound immunoablation? No Save
- MIDAS touch on TA-TMA: golden gains through active screening Save
- The Changing Impact of Human Cytomegalovirus Serology and Infection on Patient Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey in the Era of Letermovir Prophylaxis Save
- Post-transplant cyclophosphamide in matched donor transplantation: are we there yet? Save
- Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT Save
- Utilization of hematopoietic cell transplantation and cellular therapy technology in Europe and associated Countries. Using the 2022 activity survey data to correlate with economic and demographic factors. A report from the EBMT Save
- Monitoring and management of CMV and EBV after autologous haematopoietic stem cell transplantation for autoimmune diseases: a survey of the EBMT Autoimmune Diseases Working party (ADWP) Save
- In response to the letter by Howard JF and colleagues (eclinm-D-24-00922) Save